Skip to main content
TipRanks
Go Ultimate75% OFF

Michael York Insider Profile

4 Followers

Michael York, former VP & Corp. Dev at Phasebio Pharmaceuticals, holds 103.50K shares in Metacrine (Ticker: MTCR), holds 7.06K shares in Phasebio Pharmaceuticals (Ticker: PHASQ). Most recently, Michael York Sold ― shares of Metacrine on Jan 27, 2023 for an estimated value of $43.89K.

Michael York's Trading History

MTCR
Metacrine
Jan 27, 2023―Informative Sell43.89K$60.13K
PHASQ
Phasebio Pharmaceuticals
May 24, 2021―Uninformative Buy8.11K$169.42

You May Also Like

Michael York insider profile FAQ

What stocks does Michael York hold?
Michael York holds: PHASQ, MTCR stocks.
What was Michael York’s latest transaction?
Michael York’s latest transaction was an Informative Sell of $43.89K.
What was Michael York's most profitable transaction?
Michael York’s most profitable transaction was an Informative Buy of PHASQ stock on December 11, 2018. The return on the trade was -15.20%.
What is Michael York's role in Phasebio Pharmaceuticals?
Michael York's role in Phasebio Pharmaceuticals is VP & Corp. Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.